智通财经APP讯，丽珠医药(01513)公布，于 2025 年度股东会上，董事会重选朱保国先生、林楠棋先生及邱庆丰先生为第十二届董事会非执行董事;重选唐阳刚先生以及选举刘大平先生为第十二届董事会执行董事;及重选罗会远先生、崔丽婕女士、王智瑶女士以及选举康立女士为第十二届董事会独立非执行董事。
经董事会提名委员会对候选人进行资格审查，职工代表大会通过民主选举冉永梅女士为公司第十二届董事会职工代表董事。
另外，董事会同意聘任刘大平先生为公司总裁，同意聘任杜军先生、徐晓先生、陈志华先生及黄瑜璇女士为公司副总裁，同意聘任王胜先生为公司财务负责人，同意聘任刘宁女士为公司董事会秘书兼公司秘书，同意聘任夏雨女士为公司深圳证券交易所证券事务代表。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.